We are currently upgrading our website. Please bear with us if you are experiencing any loading issues.
John Collings is President, Asia Pacific, for Stryker with responsibility for all divisions within the region. He started his career with Stryker in 2016 in the Joint Replacement division where he served in various sales and marketing leadership roles, first as General Manager of the United Kingdom and then progressing to Vice President and General Manager of Europe. He was appointed to President of Stryker Asia Pacific in 2020 after assuming leadership roles with increasingly expanded responsibilities.
John is focused on driving and developing high-performing teams across the region. Having lived and worked in seven different countries, John embraces diversity and inclusion. This lays the foundation in developing mission-driven, diverse and inclusive teams that has been key to Stryker’s success. Together with Stryker’s customers, the dynamic team delivers customer-centric and differentiated innovation that drives optimal patient outcomes.
John received a Bachelor of Biology from the University of Birmingham, and Master of Research in Neuroscience from the University of Manchester. He currently resides in Singapore with his family.
Probir has three decades of medical technology industry experience and has extensively worked across medical-surgical, interventional, clinical diagnostics, infectious diseases, ophthalmology, and nutrition domains.
Probir has been with Terumo Corporation since 2012 and is currently responsible for
overseeing its operations across Asia Pacific and India. As the Regional Leader of Asia Pacific & India, he spearheads Terumo’s investments into these emerging markets for purposeful talent and business strengthening, health system scaleup through various skill interventions, and driving the long-term strategy of Terumo in Asia Pacific.
Given his keen interest in policy shaping, Probir is actively engaged in advocacy and sits on the Board of Directors for the Asia Pacific Medical Technology Association (APACMed) and Medical Technology Association of India (MTaI).
Probir also has over a decade’s teaching experience, specifically around strategy, leadership
development, coaching and performance management. His passion towards MedTech sees him mentor start-ups and entrepreneurs.
Probir resides in Singapore and is a frequent visitor to all of the Asia Pacific markets and Japan.
Lam Chee Hong is the President and a Member of the Management Board of B. Braun Asia Pacific. As President, he is responsible for the Group’s pharmaceutical and medical technology business across the region.
Chee Hong begin his career with B. Braun in 1986 as a medical sales representative. In recognition of his leadership, versatility and business performance, he was continually entrusted with additional key responsibilities and ascended through the levels in the organisation to assume the most senior leadership role in B. Braun Asia Pacific.
Based in B. Braun’s regional headquarters in Penang, Malaysia, he also oversees B. Braun Group’s largest production sites in the world with over 7,700 employees.
Chee Hong graduated with a Bachelor of Economics from the University of Malaya. He is married and has two children.
Farhana Nakhooda, GM & SVP Health Catalyst, Asia Pacific, leads the overall vision and growth strategy of the Health Catalyst business across Asia Pacific. She is passionate about improving healthcare outcomes, access to care as well as decreasing healthcare costs across the APAC region. She has extensive experience with engagement at the intersection of medicine, technology, AI and analytics. Prior to joining Health Catalyst, Farhana was the IBM Healthcare & Life Sciences solutions leader for Asia Pacific for 18 years where she played a key role in digitally enabling healthcare transformation projects across Asia Pacific, Eastern Europe and Middle East/Africa. She has more than 25 years of international experience in the healthcare and life sciences industry as a medical researcher and as a subject matter expert. Farhana has a Bachelor of Science degree (with Honors), in which she majored in Biology and Biochemistry, at the University of British Columbia. She completed her MBA at Monash Mt Eliza Business School in Melbourne, Australia.
Steven has been with Baxter since 2006 holding local and regional roles including Director Business Development Asia Pacific, Country Manager of New Zealand and Business Manager Healthcare Solutions. Prior to becoming General Manager ANZ in 2015, Steven was the Director of Healthcare Solutions and Market Access ANZ. Previously, Steven spent six years at TNT and five years at GM Holden Limited.
Vy joined Varian, now a Siemens Healthineers company, in 1998 and has held leadership positions in regulatory affairs, quality and compliance. She has been key to sharpening Varian’s focus on cancer care through acquisitions and divestments, and also in the combination of Varian and Siemens Healthineers. Her areas of expertise include global regulation, ethics and trade.
Alex Gu is Senior Vice President and President of Medtronic Greater China. Based in Shanghai, he is a member of the Medtronic Executive Committee.
Until January 2018, Alex Gu was Vice President, Regional Growth Initiatives, Greater China, leading the business development, medical and clinical affairs, emerging markets/private hospitals, and R&D functions in the region. He was also the Greater China leader for Medtronic’s Minimally Invasive Therapies Group (MITG).
Alex is a native of China. Alex holds a bachelor’s degree and master’s degree in electrical engineering from Mississippi State University. He received his MBA from the University of Chicago’s Booth School of Business. He is a Fellow of Aspen China Fellowship Program and a member of the Aspen Global Leadership Network.
Justin Leong was appointed president of ResMed’s Asian and Latin American markets in June 2020, an extension of his role as president of ResMed’s Asia Growth Markets, held since September 2018, and the region’s senior vice president since May 2016. He is also a director on the board of various ResMed subsidiaries. He joined ResMed in 2013 as vice president of Global Strategy, adding the role of General Manager of Greater China in 2015.
Before joining ResMed, Justin was a director at London-based investment firm HgCapital from 2006 to 2012, responsible for acquisitions and portfolio management, and serving on the board of directors of several European healthcare companies. From 1999 to 2004, he was a management consultant with Bain & Co. in Sydney, Boston and New York, where he advised clients on growth strategies, operational improvement projects, mergers and acquisitions.
Justin holds a Bachelor of Commerce and a Bachelor of Laws from the University of New South Wales, Sydney, and a Master of Business Administration from the Harvard Business School.
Lance Little became the Managing Director, Region Asia Pacific for Roche Diagnostics in 2012. Prior to that, he was the Managing Director of Roche Diagnostics India (including the Indian sub-region). His experience as Managing Director extends to both Roche Diagnostics Thailand and Roche Diagnostics New Zealand.
Lance joined Roche in New Zealand in 1995 in the technical support and management division of Boehringer Mannheim’s Clinical Chemistry portfolio, before moving on to sales and marketing roles. He was appointed Managing Director of Roche Diagnostics Thailand in 2008 before returning to New Zealand to take up the role of Managing Director in 2009.
Lance started his career as a Medical Laboratory Scientist, specialising in Biochemistry at Auckland Hospital Laboratory in New Zealand. Following that, he spent some time managing the Automation Laboratory at Diagnostic Laboratories in Auckland.
Stephen Morse is our senior vice president and president, Asia Pacific, a role he has held since May 2022. In this role, Stephen leads the company’s business across the Asia Pacific region and is responsible for strategy, talent development, commercial operations and the delivery of business growth. Prior to this role, Stephen served as president, Boston Scientific Japan from July 2019 to April 2022, and group vice president and general manager, Cardiovascular and Rhythm Management, Boston Scientific Japan. Prior to these roles in Japan, Stephen served as vice president, global marketing, Rhythm Management. Stephen joined Boston Scientific in July 1998 as a field clinical representative in the Rhythm Management business, moving progressively through the organization in roles spanning sales, marketing, strategy, and commercial functions. Before joining Boston Scientific, Stephen was a captain in the United States Air Force. He holds a B.Sc. in Chemical Engineering from Michigan State University, an M.B.A. in Management from Colorado State University and an M.Sc. in Financial Economics from University of London.
Marc was born in South Africa and holds commerce degrees from The Cape Peninsula University of Technology and The University of South Australia.
Prior to joining Olympus, Marc held several management positions working for a variety of technology-focused companies, including Philips and LG Electronics. His career spans numerous countries and continents including South Africa, The United Kingdom, Europe, Australia, and most recently Singapore.
Marc commenced his career with Olympus in 2004 in Sydney Australia where he served as the Managing Director for Australia and New Zealand in the Consumer Imaging business. In 2013, Marc moved to Singapore, to take on the role as Division Director of the Consumer Imaging Business for Olympus Corporation of Asia Pacific.
In 2019, Marc was promoted to Chief Executive Officer of Olympus Corporation of Asia Pacific, with full strategic and operational responsibility for the APAC Region. In addition, he also concurrently serves as the Managing Director of Olympus Singapore and sits on the board of the Asia Pacific Medical Technology Association (APACMed).
To achieve the Olympus purpose of Making people’s lives healthier, safer and more fulfilling, Marc is focused on establishing Olympus APAC as a MedTech organization known for excellence throughout the region.
Marc is married with two children and enjoys spending time with his family and the occasional ultra-marathon or competitive swim.
Tim Schmid is the Company Group Chairman, Johnson & Johnson Medical Devices, Asia Pacific where he leads the company’s efforts to bring market leading surgical, orthopedic and interventional solutions to patients in need across Asia.
Tim has been with Johnson & Johnson for over 25 years and has held diverse leadership positions in sales, strategic marketing and general management across multiple businesses and geographies. Most recently, he served as Chief Strategic Customer Officer, where he led a transformation of Johnson & Johnson’s business-to-business relationships with hospital systems in the US. Prior to this he was President of Johnson & Johnson’s surgery business, Ethicon, where led a major turnaround in the US. This included the integration of five standalone businesses and the implementation of a new go-to-market model to address the rapidly changing needs of both clinicians and health care administrators.
Tim is a global executive who, in addition to leading business transformations across multiple continents, builds strong teams that have a track record of customer orientated solutions, growth and leadership across the medical technology industry. He is a champion for the value of diversity, currently leading the company’s diversity and inclusion efforts across Asia Pacific. He was also instrumental in establishing Johnson & Johnsons global partnership with Operation Smile, focused on bringing safe and effective surgical care to children suffering from cleft lip or cleft palate.
Educated in South Africa, Canada and the United Kingdom, Tim has lived and worked in six countries on four continents. He earned his undergraduate degree from the University of Western Ontario in Canada, and an MBA from Richmond University in the United Kingdom.
Paul Tan is the Divisional Vice President, APAC of Abbott Vascular Division. Paul joined Abbott in 2014 as General Manager, China. He was promoted to Divisional Vice President & General Manager, Greater China in 2017 and to current role in September 2019. Prior to joining Abbott, Paul was General Manager, China for Molnlycke Health Care.
Paul has been in the healthcare industry for over 20 years and has held leadership positions in companies, including Genzyme Corporation as a Commercial Manager and Teleflex as General Manager of Greater China.
Paul holds a master’s degree in structural engineering from Tongji University and a master’s in business administration from China Europe International Business School (CEIBS).
Pavan Kumar Mocherla is the Executive Vice President and President Greater Asia at Becton Dickinson.
With a distinctive ability to handle both big and small teams, Pavan brings people management skills, strategic thinking, analytical ability, learning agility and action orientation to the teams and assignments he manages. Some of his most satisfying successes have been leading teams on accelerated growth trajectories.
James Lim, Executive Vice President and President, Greater Asia for Becton Dickinson (BD), sits on BD’s Global Leadership Management Committee reporting to the CEO. Based in Singapore, BD’s regional headquarters, James leads the business operations in China, Japan, Taiwan, Hong Kong, Australia, and New Zealand, Korea, SEA, India and Pakistan.
James joined BD in 1994 from Seagate International. Starting as an Engineering and Facility Manager for BD Medical (Singapore), after a 3-year assignment in R&D, he became a Plant Manager in 2000. In 2003, he was promoted to the role of the Director of Operations for Asia Pacific, where he was responsible for the regional manufacturing and supply chain functions, overseeing plants operating in Singapore, Bawal, India, and Suzhou, China.
In April 2008, James was appointed as the Vice President for Central and Asia Pacific, holding responsibility for the Central Asia Business Management and support functions for the entire Asia Pacific region.
Four years later, James was appointed as President of Greater Asia and an Executive Member of the company, becoming the first Asian leader to take office in the region’s 30-year history.
A strong believer in developing and retaining the best of talents, James was conferred the Leading CEO award by the Singapore Human Resources Institute (SHRI) in 2014. The award was testimony to his championship of innovative and effective HR ideas and practices and demonstration of leadership commitment to talent development within the industry.
James received his early education in Malaysia and continued to study the National University of Singapore, where he graduated with a Mechanical Engineering degree.
Married and with two teenage sons, James tries to spend as much time as possible with them between his business travels. He is passionate about automotive and is an avid fitness enthusiast.
Art Butcher is Executive Vice President and President for Boston Scientific in the Asia Pacific region, a role he has held since February 2020. Currently based in Singapore, Art is responsible for the overseeing the continued growth of our business across Asia Pacific in line with our company values. He is a member of the Boston Scientific global executive committee.
Art has been with Boston Scientific for over 20 years. Prior to his current role, Art was President, Endoscopy with global responsibility for developing and bringing to market less invasive devices for treating gastrointestinal and pulmonary conditions. He was previously Vice President and General Manager, Endoscopy in Japan.
Art has held a variety of marketing and strategic planning management positions within the Endoscopy, Urology and Pelvic Health businesses, including Vice President of Global Marketing (Endoscopy) and Vice President of New Business Development and Strategic Planning (Urology and Women’s Health). He joined Boston Scientific in 1997 as a sales representative in the Urology business.
Art holds a BA in International Relations from the University of Pennsylvania and an MBA from Columbia University.
Chris Lee is President of Medtronic, Asia Pacific and serves as a member of the Medtronic Executive Committee. He oversees the Medtronic APAC region where the company has presence in more than 20 countries with about 10,000 employees across the region. Chris joined Medtronic in 2012 as President of the Greater China region and was named as President of APAC in December of 2017. Under his leadership, the Greater China region achieved five consecutive years of double-digit growth by bringing meaningful innovation and expanding access to more patients locally.
Chris has a strong track record of global leadership in the healthcare industry — both in pharmaceutical and medical technology. He is known for his inclusive leadership style, commitment to meritocracy, and proven business success. During his time in China, Chris developed strategic partnerships with the Chinese government and was a strong supporter of corporate social responsibility — leading the company’s effective relief efforts to respond to the Lushan earthquake in Sichuan Province.
Prior to Medtronic, Chris was Regional Head and Senior Vice President, APAC at Bayer HealthCare where he was responsible for overall operations in the region, including pharmaceuticals, consumer over-the-counter, animal health, and medical devices. Chris has also held roles of increasing responsibility in several multinational companies, including Bristol Myers Squibb and Merck Sharpe and Dohme, while based in APAC and the U.S., respectively.
Chris is a pioneer in the management of workplace happiness and is the author of two bestselling books, one on emotional management and one on marketing. He was also formerly an executive director in the pharmaceutical industry associations of China (RDPAC), Australia (Medicines Australia), and Korea (Korea Pharma).
Chris serves on the board of the Asia Pacific Medical Technology Association (APACMed).
Chris holds a bachelor’s degree from the University of Arizona, Tucson and a master’s degree from the American Graduate School of International Management (Thunderbird). He is fluent in English and Korean, with a good understanding of Mandarin Chinese and Japanese.